Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Czock

Showing results (41-50 of 104) with videos related to

Pageof 11
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 21, 2005
Clinical course of haemodialysis patients with malignancies and dose-adjusted chemotherapyBenjamin Boesler, David Czock, Frieder Keller, et al.
Journal of Clinical Medicine|July 27, 2022
Shortcomings of Administrative Data to Derive Preventive Strategies for Inhospital Drug-Induced Acute Kidney Failure-Insights from Patient Record AnalysisStefanie Amelung, David Czock, Markus Thalheimer, et al.
Journal of the American Medical Informatics Association : JAMIA|April 26, 2015
Tailoring of alerts substantially reduces the alert burden in computerized clinical decision support for drugs that should be avoided in patients with renal diseaseDavid Czock, Michael Konias, Hanna M Seidling, et al.
Therapeutic Drug Monitoring|December 31, 2010
Modulators of very low voriconazole concentrations in routine therapeutic drug monitoringArwa Hassan, Jürgen Burhenne, Klaus-Dieter Riedel, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 4, 2026
A UPLC-MS/MS assay for the quantification of the novel viral helicase-primase drug candidate adibelivir (IM-250) in human specimenCindy Bay, Mariano Bergamino, Max Sauter, et al.
BMC Cancer|August 11, 2020
Protocol of the VICTORIA study: personalized vitamin D supplementation for reducing or preventing fatigue and enhancing quality of life of patients with colorectal tumor - randomized intervention trialBen Schöttker, Sabine Kuznia, Dana Clarissa Laetsch, et al.
Clinical Pharmacology in Drug Development|February 28, 2021
Differential Effect of a Continental Breakfast on Tacrolimus Formulations With Different Release CharacteristicsAndrea Huppertz, Johanna Bollmann, Rouven Behnisch, et al.
BMC Medical Informatics and Decision Making|July 3, 2025
Towards a prescribing monitoring system for medication safety evaluation within electronic health records: a scoping reviewCamilo Scherkl, Theresa Dierkes, Michael Metzner, et al.
British Journal of Clinical Pharmacology|March 27, 2019
Perpetrator effects of ciclosporin (P-glycoprotein inhibitor) and its combination with fluconazole (CYP3A inhibitor) on the pharmacokinetics of rivaroxaban in healthy volunteersAntonia Brings, Marie-Louise Lehmann, Kathrin I Foerster, et al.
Pharmacology Research & Perspectives|April 18, 2024
Coadministration of fluconazole to boost subtherapeutic sirolimus concentrations: A case reportCamilo Scherkl, Andreas D Meid, Sven E Cuntz, et al.
Pageof 11

Showing results (41-50 of 104) with videos related to

Sort By:
Pageof 11
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 21, 2005
Clinical course of haemodialysis patients with malignancies and dose-adjusted chemotherapyBenjamin Boesler, David Czock, Frieder Keller, et al.
Journal of Clinical Medicine|July 27, 2022
Shortcomings of Administrative Data to Derive Preventive Strategies for Inhospital Drug-Induced Acute Kidney Failure-Insights from Patient Record AnalysisStefanie Amelung, David Czock, Markus Thalheimer, et al.
Journal of the American Medical Informatics Association : JAMIA|April 26, 2015
Tailoring of alerts substantially reduces the alert burden in computerized clinical decision support for drugs that should be avoided in patients with renal diseaseDavid Czock, Michael Konias, Hanna M Seidling, et al.
Therapeutic Drug Monitoring|December 31, 2010
Modulators of very low voriconazole concentrations in routine therapeutic drug monitoringArwa Hassan, Jürgen Burhenne, Klaus-Dieter Riedel, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 4, 2026
A UPLC-MS/MS assay for the quantification of the novel viral helicase-primase drug candidate adibelivir (IM-250) in human specimenCindy Bay, Mariano Bergamino, Max Sauter, et al.
BMC Cancer|August 11, 2020
Protocol of the VICTORIA study: personalized vitamin D supplementation for reducing or preventing fatigue and enhancing quality of life of patients with colorectal tumor - randomized intervention trialBen Schöttker, Sabine Kuznia, Dana Clarissa Laetsch, et al.
Clinical Pharmacology in Drug Development|February 28, 2021
Differential Effect of a Continental Breakfast on Tacrolimus Formulations With Different Release CharacteristicsAndrea Huppertz, Johanna Bollmann, Rouven Behnisch, et al.
BMC Medical Informatics and Decision Making|July 3, 2025
Towards a prescribing monitoring system for medication safety evaluation within electronic health records: a scoping reviewCamilo Scherkl, Theresa Dierkes, Michael Metzner, et al.
British Journal of Clinical Pharmacology|March 27, 2019
Perpetrator effects of ciclosporin (P-glycoprotein inhibitor) and its combination with fluconazole (CYP3A inhibitor) on the pharmacokinetics of rivaroxaban in healthy volunteersAntonia Brings, Marie-Louise Lehmann, Kathrin I Foerster, et al.
Pharmacology Research & Perspectives|April 18, 2024
Coadministration of fluconazole to boost subtherapeutic sirolimus concentrations: A case reportCamilo Scherkl, Andreas D Meid, Sven E Cuntz, et al.
Pageof 11